查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1926878

全尺寸行動C臂市場（按購買類型、技術、應用和最終用戶分類）－2026-2032年全球預測

Full-size Mobile C-arms Market by Purchase Type, Technology, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，全尺寸行動 C 型臂市場價值將達到 19.5 億美元，到 2026 年將成長至 20.8 億美元，到 2032 年將達到 31.7 億美元，複合年成長率為 7.16%。

關鍵市場統計數據
基準年 2025 19.5億美元
預計年份：2026年 20.8億美元
預測年份 2032 31.7億美元
複合年成長率 (%) 7.16%

對影響醫療服務環境中採用全尺寸移動式C型臂的當代臨床和採購促進因素進行清晰分析

本執行摘要總結了關於全尺寸移動式C臂機的關鍵觀察結果，並闡述了影響其在現代醫療系統中應用和採購的技術、監管和臨床趨勢。隨著臨床團隊尋求兼具精準成像和高效工作流程的設備，以及醫療系統優先考慮能夠帶來可衡量臨床價值的資本投資，行動影像領域正在迅速發展。本文從設備外形規格、成像流程改進以及不同醫療環境下的營運需求等方面，對這些趨勢進行了梳理。

檢測器創新、軟體生態系統以及門診手術的興起如何重塑移動影像系統的採購重點和臨床期望

過去幾年，一系列變革正在重塑消費者對全尺寸移動式C臂設備的期望，加速從舊有系統向模組化、軟體驅動平台的過渡。平板檢測器技術和先進影像處理演算法的進步提高了複雜介入手術中的診斷信心，同時實現了劑量降低策略，滿足了日益嚴格的監管要求和病患安全期望。同時，製造商正在擴展其設備的軟體生態系統，以促進影像整合、分析和遠端支持，從而將臨床價值提案到硬體效能之外。

評估供應鏈調整和籌資策略的最新趨勢，以應對關稅趨勢，從而控制醫療影像診斷設備採購成本。

美國於2025年實施的政策變遷和關稅措施引入了新的成本促進因素，這些因素對全球醫療影像診斷設備的供應鏈產生了連鎖反應。影響關鍵零件、子組件和成品的關稅調整提高了部分進口產品的到岸成本，迫使採購團隊重新評估其籌資策略，並與供應商就整體擁有成本進行更深入的討論。這些關稅的影響並非均勻分佈，而是因零件產地、組裝地點和合約條款而異。這意味著一些供應商自行承擔了成本，而另一些供應商則將價格上漲轉嫁給了客戶。

詳細的細分分析揭示了採購方式、臨床環境、檢測器選擇和手術應用如何共同決定採購規格。

分析這種細分市場的細微差別，可以揭示購買類型、最終用戶環境、檢測器技術和臨床應用如何相互作用，從而影響設備需求和購買行為。根據購買類型，市場分別針對全新產品和翻新產品進行考察，此差異會影響保固結構、軟體升級合格和殘值預期。安裝新系統的機構通常期望獲得多年服務協議和可預測的升級路徑，而購買翻新產品的機構則往往優先考慮資金效率和即時可用性，同時接受在保固範圍和長期軟體相容性方面的妥協。

區域採購慣例、服務網路和監管差異如何影響全球醫療保健市場的採用模式和供應商策略

區域趨勢對全尺寸移動式C臂系統的供應鏈配置、法規要求和臨床應用模式有顯著影響。在美洲，醫院優先考慮互通性、劑量報告和完善的服務網路，並且通常期望獲得延長的保固期和快速的現場服務，以支持高手術量的環境。相較之下，在歐洲、中東和非洲（EMEA），監管環境、報銷框架和基礎設施成熟度在不同地區差異顯著，迫使供應商調整其產品和服務模式以滿足國家和地區的具體要求。雖然EMEA部分地區對價格較為敏感，但三級醫療機構對先進影像功能的需求依然強勁。

分析供應商在硬體創新、售後服務和軟體合作方面的策略，這些策略將影響行動成像領域的競爭格局。

製造商之間的競爭動態正朝著融合卓越硬體效能與軟體支援服務模式的方向發展。領先的技術開發人員優先考慮提升檢測器靈敏度、改進降噪演算法以及升級用戶介面，以縮短檢查準備時間。同時，差異化的售後服務，例如預測性維護分析、遠距離診斷和結構化培訓項目，正日益成為供應商價值提案的核心。影像設備製造商與軟體供應商之間的策略聯盟正在加速交付支援影像工作流程、劑量追蹤和臨床文件記錄的整合解決方案。

經營團隊可以採取切實可行的採購和臨床整合步驟，以降低風險、提高運轉率並最大限度地發揮行動成像投資的臨床價值。

產業領導者可以採取以下幾個切實可行的步驟，使其籌資策略和臨床整合策略與當前的市場動態和業務重點保持一致。首先，組成跨職能團隊，匯集臨床、生物醫學工程和供應鏈的專業知識，以明確反映預期用例和吞吐量目標的效能和服務要求。這種方法可以避免規範臃腫，並確保軟體升級路徑和備件供應保證等重要方面都包含在合約條款中。其次，優先要求供應商提供詳細的總成本披露資訊，包括服務響應時間、零件可用性和升級許可模式。這種透明度可以減少後續的採購糾紛，並有助於制定可預測的預算。

採用透明的混合調查方法，結合專家訪談、技術檢驗和監管審查，以確保為決策者提供可靠、可操作的見解。

本分析所依據的研究採用了嚴謹的混合方法，結合了一手資料和結構化的二手資料研究，以檢驗技術、臨床和商業性的論點。一手資料研究包括對臨床負責人、生物醫學工程師、採購負責人和供應商產品經理的訪談，以獲取關於設備性能、服務期望和購買因素的第一手資訊。這些定性研究結果輔以對設備規格、臨床工作流程文件和供應商服務資料的觀察性審查，以對所報告的功能進行三角驗證。

總之，評估強調，影像效能、可維護性和採購過程的透明度相結合，是成功採用技術的關鍵因素。

總而言之，全尺寸移動式C臂正處於一個轉折點，檢測器精度、軟體生態系統和售後服務的整合正在定義下一代臨床能力。醫療機構越來越傾向於選擇不僅成像性能卓越，而且維護性可預測，並能與臨床工作流程無縫整合的系統。關稅趨勢和區域供應鏈動態增加了採購決策的複雜性，進一步凸顯了明確的合約條款以及供應商對零件和升級服務的承諾的重要性。

目錄

第1章：序言

第2章調查方法

  • 研究設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查前提
  • 調查限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會地圖
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：按購買類型分類的全尺寸移動式C臂市場

  • 新的
  • 再生產品

9. 按技術分類的全尺寸移動式C臂市場

  • 平板檢測器
  • 影像增強器

第10章 依應用分類的全尺寸移動式C臂市場

  • 循環系統
  • 胃腸病學
  • 整形外科
  • 泌尿系統

第11章 以最終用戶分類的全尺寸移動式C臂市場

  • 門診手術中心
  • 診斷影像中心
  • 醫院

第12章：各區域全尺寸移動式C臂市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章 全尺寸移動式C臂市場（依類別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 各國全尺寸移動式C臂市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章：美國全尺寸移動式C臂市場

第16章 中國全尺寸移動式C臂市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Canon Medical Systems Corporation
  • DMS Group
  • Fujifilm Holdings Corporation
  • General Electric Company
  • Koninklijke Philips NV
  • Mindray Medical International Limited
  • OrthoScan, Inc.
  • Planmed Oy
  • Shimadzu Corporation
  • Siemens Healthineers AG
  • Villa Sistemi Medicali Spa
  • Ziehm Imaging GmbH
Product Code: MRR-4F7A6D4FF350

The Full-size Mobile C-arms Market was valued at USD 1.95 billion in 2025 and is projected to grow to USD 2.08 billion in 2026, with a CAGR of 7.16%, reaching USD 3.17 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.95 billion
Estimated Year [2026] USD 2.08 billion
Forecast Year [2032] USD 3.17 billion
CAGR (%) 7.16%

A clear framing of contemporary clinical and procurement drivers influencing full-size mobile C-arm adoption across healthcare delivery settings

This executive summary synthesizes critical observations on full-size mobile C-arms, describing the technological, regulatory, and clinical dynamics that are shaping adoption and procurement in contemporary healthcare systems. The landscape of mobile imaging is evolving rapidly as clinical teams seek devices that combine precision imaging with workflow efficiency, and as health systems prioritize capital investments that deliver measurable clinical value. This document frames those developments in the context of device form factors, image chain improvements, and the operational demands of diverse care settings.

The following analysis emphasizes how advances in detector technology, image processing, and user interface design are translating into new clinical capabilities across interventional specialties. It also highlights how provider priorities-such as procedure throughput, radiation dose management, and interoperability with electronic health records and PACS-are driving procurement specifications. Throughout, the narrative connects clinical imperatives with supply chain realities and procurement strategies to provide an integrated view useful to executives, clinical leaders, and sourcing professionals.

How detector innovations, software ecosystems, and outpatient procedural growth are reshaping procurement priorities and clinical expectations for mobile imaging systems

The past several years have seen a series of transformative shifts that are redefining what buyers expect from full-size mobile C-arms, and these shifts are accelerating the transition from legacy systems toward modular, software-enabled platforms. Advances in flat panel detector technology and smarter image processing algorithms have elevated diagnostic confidence for complex interventional procedures, while simultaneously enabling dose reduction strategies that satisfy growing regulatory and patient safety expectations. In parallel, manufacturers are expanding the software ecosystems of their devices to facilitate image integration, analytics, and remote support, which extends the clinical value proposition beyond pure hardware performance.

Operationally, there is a pronounced move toward devices optimized for hybrid environments and ambulatory procedural suites, where space constraints and workflow flexibility are paramount. This trend has been reinforced by the rising prevalence of outpatient and ambulatory surgical centers performing advanced endovascular and orthopedic procedures. Moreover, systems designed to minimize setup times and streamline documentation are gaining favor as providers seek to maximize throughput without compromising image quality. Taken together, these shifts point to a healthcare environment where adaptability, connectivity, and lifecycle serviceability are as important as raw imaging performance.

Assessment of recent tariff-driven supply chain adjustments and procurement strategies that are moderating cost exposure for medical imaging acquisitions

Policy changes and tariff actions implemented in the United States during 2025 have introduced new cost considerations that ripple across global supply chains for medical imaging equipment. Tariff adjustments affecting key components, subassemblies, and finished devices have increased landed costs for some imports, prompting procurement teams to re-evaluate sourcing strategies and to engage more closely with vendors on total cost of ownership. These tariff effects are not uniform; they vary by component origin, assembly footprint, and contractual terms, which means that some suppliers absorbed costs while others passed increases through to customers.

In response, vendors have accelerated efforts to localize manufacturing where feasible, diversify supplier networks, and redesign certain assemblies to use alternate components that are not subject to new duties. Buyers, for their part, have extended lead times and re-assessed service and spare parts agreements to mitigate exposure to sudden tariff-driven price variability. Clinicians and capital planners should note that while tariff impacts can be managed through procurement strategy, they increase the transactional complexity of purchases and emphasize the importance of clarity in total acquisition and lifecycle servicing commitments. Consequently, procurement professionals are placing higher value on transparent pricing, fixed-term service agreements, and supplier commitments to spare parts availability.

Detailed segmentation analysis revealing how purchase modality, clinical setting, detector choice, and procedural application collectively determine procurement specifications

A nuanced view of segmentation reveals how purchase modality, end user environment, detector technology, and clinical application intersect to shape device requirements and purchasing behavior. Based on Purchase Type, market is studied across New and Refurbished, and this distinction carries implications for warranty structures, software upgrade eligibility, and residual value expectations. Facilities acquiring new systems typically expect multi-year service contracts and predictable upgrade paths, whereas purchasers of refurbished units frequently prioritize capital efficiency and immediate availability, accepting trade-offs in warranty scope and long-term software compatibility.

Based on End User, market is studied across Ambulatory Surgical Centers, Diagnostic Imaging Centers, and Hospitals, a segmentation that highlights starkly different workflow and space constraints as well as varied clinical case mixes. Ambulatory surgical centers often prioritize compact footprint and rapid setup, diagnostic imaging centers emphasize throughput and cross-modality integration, and hospitals require versatile machines that can serve a broad range of interventional specialties. Based on Technology, market is studied across Flat Panel Detector and Image Intensifier, an axis that underscores differences in image quality, dose management, and cost-to-upgrade considerations. Flat panel detectors deliver improved spatial resolution and are increasingly preferred for complex interventional procedures, while image intensifiers remain relevant where budget constraints and legacy serviceability are key. Based on Application, market is studied across Cardiovascular, Gastroenterology, Orthopedic, and Urology, and this application-focused segmentation clarifies how modality-specific clinical workflows drive particular feature sets such as roadmapping for vascular work, c-arm angulation for spinal procedures, and special image processing modes for endoscopic-assisted interventions.

By synthesizing these segmentation vectors, procurement leads and clinical managers can better align specifications with intended use cases, anticipate service and training needs, and design acquisition strategies that reflect the interplay of capital constraints, clinical priorities, and expected device utilization.

How regional procurement practices, service networks, and regulatory diversity are determining adoption patterns and supplier strategies across global healthcare markets

Regional dynamics exert a powerful influence on supply chain configurations, regulatory expectations, and clinical adoption patterns for full-size mobile C-arms. In the Americas, health systems emphasize interoperability, dose reporting, and comprehensive service networks, and buyers often expect extended warranty and rapid field service to support high-volume procedural environments. Meanwhile, Europe, Middle East & Africa present a heterogeneous landscape where regulatory regimes, reimbursement frameworks, and infrastructure maturity vary considerably, prompting vendors to tailor product offerings and service models to country- or region-specific requirements. In parts of EMEA, price sensitivity coexists with strong clinical demand for advanced imaging features in tertiary referral centers.

Across Asia-Pacific, rapid hospital expansion, investments in tertiary care, and a burgeoning private hospital sector have driven demand for imaging platforms that balance advanced capability with cost-efficient servicing and local technical support. Regional pricing strategies, distributor networks, and local regulatory approvals shape product availability and deployment timelines across these geographies. Vendors that establish strong regional partnerships and invest in regional technical training and spare parts infrastructure tend to achieve more predictable uptake and higher customer satisfaction scores among institutional buyers.

An appraisal of vendor strategies showing how hardware innovation, aftermarket services, and software partnerships are shaping competitive positioning in mobile imaging

Competitive dynamics among manufacturers are converging toward a set of capabilities that combine hardware excellence with software-enabled services and support models. Leading technology developers have prioritized upgrades in detector sensitivity, noise reduction algorithms, and user interfaces that reduce procedure preparation time. At the same time, differentiated aftermarket offerings-such as predictive maintenance analytics, remote diagnostics, and structured training programs-are increasingly central to vendor value propositions. Strategic partnerships between imaging OEMs and software providers have accelerated the delivery of integrated solutions that support imaging workflow, dose tracking, and clinical documentation.

From a commercial standpoint, established global suppliers are leveraging their service footprints and financing programs to reduce purchasing friction, while niche and regional manufacturers compete on modularity, cost efficiency, and niche clinical feature sets. Several manufacturers have introduced refresh and refurbishment programs that extend device lifecycles and provide lower-cost entry points for budget-constrained buyers. Clinical leaders evaluating supplier options should weigh both the baseline imaging performance and the supplier's demonstrated capability to support ongoing software updates, training, and parts logistics over the expected lifespan of the device.

Practical procurement and clinical integration steps that executives can implement to reduce risk, improve uptime, and maximize the clinical value of mobile imaging investments

Industry leaders can take several practical steps to align their procurement and clinical integration strategies with current market dynamics and operational priorities. First, integrate cross-functional teams-combining clinical, biomedical engineering, and supply chain expertise-to define precise performance and service requirements that reflect intended use cases and throughput goals. This approach reduces specification creep and ensures that contractual terms cover essential aspects such as software upgrade pathways and spare parts commitments. Second, prioritize requests for detailed total cost disclosures from suppliers that include service response times, parts availability, and upgrade licensing models; clarity here reduces downstream procurement disputes and supports predictable budgeting.

Third, consider phased acquisition strategies that allow facilities to pilot newer detector technologies or refurbished units in lower-risk procedural areas before broader deployment. Fourth, negotiate fixed-term service levels and parts availability guarantees to mitigate exposure to supply chain volatility and tariff-related cost variation. Fifth, invest in training programs and remote support arrangements that shorten onboarding and maximize clinical utilization. By following these steps, hospital and clinic leaders can secure devices that deliver clinical value while minimizing operational disruption and unexpected lifecycle costs.

A transparent mixed methods research approach blending expert interviews, technical validation, and regulatory review to ensure robust and actionable insights for decision makers

The research underpinning this analysis was constructed through a rigorous mixed-methods approach combining primary engagements and structured secondary inquiry designed to validate technical, clinical, and commercial claims. Primary research included interviews with clinical leaders, biomedical engineers, procurement professionals, and vendor product managers to capture firsthand perspectives on device performance, service expectations, and purchasing drivers. These qualitative insights were complemented by observational reviews of device specifications, clinical workflow documentation, and vendor service literature to triangulate reported capabilities.

Secondary research encompassed regulatory guidance, standards for radiation safety and reporting, and publicly available technical literature on detector performance and imaging algorithms. Data synthesis included cross-referencing interview inputs with product literature and service contract terms to identify consistent patterns and divergent claims. Quality assurance measures included expert review cycles with clinical domain specialists and validation of technical assertions against manufacturer documentation. The methodology prioritized transparency in assumptions and sought to surface areas of uncertainty, enabling readers to interpret findings with appropriate context.

Concluding assessment emphasizing the convergence of imaging performance, serviceability, and procurement clarity as the decisive factors for successful technology adoption

In summary, full-size mobile C-arms are at an inflection point where detector fidelity, software ecosystems, and aftermarket services converge to define the next generation of clinical capability. Providers are increasingly selecting systems that offer not only superior imaging performance but also predictable serviceability and seamless integration with clinical workflows. Tariff developments and regional supply chain dynamics have added complexity to procurement decisions, reinforcing the value of explicit contractual terms and supplier commitments on parts and upgrades.

Looking ahead, success for clinical and purchasing leaders will depend on disciplined specification development, cross-functional decision making, and active engagement with suppliers on lifecycle support and cost transparency. Facilities that align device selection with precise clinical use cases and that secure robust service agreements will be best positioned to deliver high-quality interventional care while controlling operational risk and total lifecycle complexity.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Full-size Mobile C-arms Market, by Purchase Type

  • 8.1. New
  • 8.2. Refurbished

9. Full-size Mobile C-arms Market, by Technology

  • 9.1. Flat Panel Detector
  • 9.2. Image Intensifier

10. Full-size Mobile C-arms Market, by Application

  • 10.1. Cardiovascular
  • 10.2. Gastroenterology
  • 10.3. Orthopedic
  • 10.4. Urology

11. Full-size Mobile C-arms Market, by End User

  • 11.1. Ambulatory Surgical Centers
  • 11.2. Diagnostic Imaging Centers
  • 11.3. Hospitals

12. Full-size Mobile C-arms Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Full-size Mobile C-arms Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Full-size Mobile C-arms Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Full-size Mobile C-arms Market

16. China Full-size Mobile C-arms Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Canon Medical Systems Corporation
  • 17.6. DMS Group
  • 17.7. Fujifilm Holdings Corporation
  • 17.8. General Electric Company
  • 17.9. Koninklijke Philips N.V.
  • 17.10. Mindray Medical International Limited
  • 17.11. OrthoScan, Inc.
  • 17.12. Planmed Oy
  • 17.13. Shimadzu Corporation
  • 17.14. Siemens Healthineers AG
  • 17.15. Villa Sistemi Medicali Spa
  • 17.16. Ziehm Imaging GmbH

LIST OF FIGURES

  • FIGURE 1. GLOBAL FULL-SIZE MOBILE C-ARMS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL FULL-SIZE MOBILE C-ARMS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL FULL-SIZE MOBILE C-ARMS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY PURCHASE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES FULL-SIZE MOBILE C-ARMS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA FULL-SIZE MOBILE C-ARMS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL FULL-SIZE MOBILE C-ARMS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY PURCHASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY NEW, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY NEW, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY NEW, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY REFURBISHED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY REFURBISHED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY REFURBISHED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY FLAT PANEL DETECTOR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY FLAT PANEL DETECTOR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY FLAT PANEL DETECTOR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY IMAGE INTENSIFIER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY IMAGE INTENSIFIER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY IMAGE INTENSIFIER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY CARDIOVASCULAR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY CARDIOVASCULAR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY GASTROENTEROLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY GASTROENTEROLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY GASTROENTEROLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY ORTHOPEDIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY ORTHOPEDIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY ORTHOPEDIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY UROLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY UROLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY UROLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. AMERICAS FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 41. AMERICAS FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY PURCHASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 42. AMERICAS FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 43. AMERICAS FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 44. AMERICAS FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 45. NORTH AMERICA FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. NORTH AMERICA FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY PURCHASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 47. NORTH AMERICA FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 48. NORTH AMERICA FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 49. NORTH AMERICA FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 50. LATIN AMERICA FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. LATIN AMERICA FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY PURCHASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 52. LATIN AMERICA FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 53. LATIN AMERICA FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 54. LATIN AMERICA FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 55. EUROPE, MIDDLE EAST & AFRICA FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 56. EUROPE, MIDDLE EAST & AFRICA FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY PURCHASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 58. EUROPE, MIDDLE EAST & AFRICA FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 59. EUROPE, MIDDLE EAST & AFRICA FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 60. EUROPE FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. EUROPE FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY PURCHASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 62. EUROPE FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 63. EUROPE FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 64. EUROPE FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 65. MIDDLE EAST FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. MIDDLE EAST FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY PURCHASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 67. MIDDLE EAST FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 68. MIDDLE EAST FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 69. MIDDLE EAST FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 70. AFRICA FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. AFRICA FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY PURCHASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 72. AFRICA FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 73. AFRICA FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 74. AFRICA FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 75. ASIA-PACIFIC FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. ASIA-PACIFIC FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY PURCHASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 77. ASIA-PACIFIC FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 78. ASIA-PACIFIC FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 79. ASIA-PACIFIC FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. ASEAN FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. ASEAN FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY PURCHASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 83. ASEAN FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 84. ASEAN FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 85. ASEAN FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 86. GCC FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GCC FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY PURCHASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 88. GCC FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 89. GCC FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 90. GCC FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 91. EUROPEAN UNION FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. EUROPEAN UNION FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY PURCHASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 93. EUROPEAN UNION FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPEAN UNION FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 95. EUROPEAN UNION FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 96. BRICS FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. BRICS FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY PURCHASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 98. BRICS FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 99. BRICS FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 100. BRICS FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 101. G7 FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. G7 FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY PURCHASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 103. G7 FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 104. G7 FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 105. G7 FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 106. NATO FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 107. NATO FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY PURCHASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 108. NATO FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 109. NATO FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 110. NATO FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. UNITED STATES FULL-SIZE MOBILE C-ARMS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 113. UNITED STATES FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY PURCHASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 114. UNITED STATES FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 115. UNITED STATES FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 116. UNITED STATES FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 117. CHINA FULL-SIZE MOBILE C-ARMS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 118. CHINA FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY PURCHASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 119. CHINA FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 120. CHINA FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 121. CHINA FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)